Acellular mucin in lymph nodes isolated from treatment-naïve colorectal cancer resections: A clinicopathologic analysis of 16 cases Journal Article
| Authors: | Lapinski, J. E.; Khorana, A. A.; Rybicki, L.; Firat, C.; Lee, H.; Piotti, K.; Lewis, E. H. 3rd; McNamara, M.; Deshpande, V.; Shia, J.; Patil, D. T. |
| Article Title: | Acellular mucin in lymph nodes isolated from treatment-naïve colorectal cancer resections: A clinicopathologic analysis of 16 cases |
| Abstract: | Lymph nodes with acellular mucin harvested from treated colorectal cancers (CRC) are staged as pN0. However, there is variability among pathologists while reporting the pN stage when acellular mucin is found within nodes of untreated CRCs. While the UICC guidelines suggest staging them as pN1, the AJCC and CAP do not offer any recommendations. In order to characterize their clinicopathologic features and outcome, we compared 16 untreated CRCs (study group; mean age: 68 years) harboring nodes with acellular mucin with 34 pN0 and 25 pN1 untreated CRC controls. All tumors were unifocal; 12 (75%) were right-sided lesions. Most cases (75%) showed one node with acellular mucin (range: 1–3). MMR-deficient tumors were significantly more common in the study group (83%) compared to pN0 (33%; p = 0.006) and pN1 controls (8%; p < 0.001). The overall survival of study group patients was closer to pN0 compared to pN1 controls; however, this difference was not statistically significant. In conclusion, untreated CRC that harbor acellular mucin within lymph nodes commonly present as right-sided, MMR-deficient tumors in older women that show a non-mucinous phenotype. While the limited number of cases precludes us from making any formal recommendations about staging, we suggest that the finding of acellular mucin in a node should prompt evaluation of deeper levels (with or without cytokeratin immunohistochemistry) and submission of all pericolonic fat for additional lymph node harvest. Whether acellular mucin in nodes of untreated CRCs is related to the indolent biology of the disease, a robust local immune response or MMR deficiency requires further investigation. © 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
| Keywords: | lymph nodes; colon cancer; untreated; acellular mucin |
| Journal Title: | Virchows Archiv |
| Volume: | 481 |
| Issue: | 1 |
| ISSN: | 0945-6317 |
| Publisher: | Springer |
| Date Published: | 2022-07-01 |
| Start Page: | 63 |
| End Page: | 72 |
| Language: | English |
| DOI: | 10.1007/s00428-022-03332-5 |
| PUBMED: | 35513610 |
| PROVIDER: | scopus |
| PMCID: | PMC9979094 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 July 2022 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work